ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.
Is Sp Tech

Is Sp Tech (IUIT)

33.00
-0.83
(-2.45%)
마감 12 1월 1:30AM

실시간 스트리밍 인용문, 아이디어 및 실시간 토론을 위한 허브

주요 통계 및 세부정보

가격
33.00
매수가
33.01
매도가
33.03
거래량
469,213
32.965 일간 변동폭 33.88
0.00 52주 범위 0.00
전일 종가
33.83
개장가
33.76
최근 거래 시간
207
@
33
(O)
마지막 거래 시간
평균 볼륨(3m)
-
재정 규모
US$ 15,615,221
VWAP
33.2796

IUIT 최신 뉴스

iShares V S&P 500 Info Tech Sc $Acc Net Asset Value(s)

iShares V S&P 500 Info Tech Sc $Acc 10 January 2025   FUND: iShares S&P 500 Information Technology Sector UCITS ETF USD (Acc) DEALING DATE: 9-Jan-25 NAV PER SHARE: Fund Holiday    ...

iShares V S&P 500 Info Tech Sc $Acc Net Asset Value(s)

iShares V S&P 500 Info Tech Sc $Acc 09 January 2025   FUND: iShares S&P 500 Information Technology Sector UCITS ETF USD (Acc) DEALING DATE: 8-Jan-25 NAV PER SHARE: Official NAV USD...

iShares V S&P 500 Info Tech Sc $Acc Net Asset Value(s)

iShares V S&P 500 Info Tech Sc $Acc 08 January 2025   FUND: iShares S&P 500 Information Technology Sector UCITS ETF USD (Acc) DEALING DATE: 7-Jan-25 NAV PER SHARE: Official NAV USD...

iShares V S&P 500 Info Tech Sc $Acc Net Asset Value(s)

iShares V S&P 500 Info Tech Sc $Acc 07 January 2025   FUND: iShares S&P 500 Information Technology Sector UCITS ETF USD (Acc) DEALING DATE: 6-Jan-25 NAV PER SHARE: Official NAV USD...

iShares V S&P 500 Info Tech Sc $Acc Net Asset Value(s)

iShares V S&P 500 Info Tech Sc $Acc 06 January 2025   FUND: iShares S&P 500 Information Technology Sector UCITS ETF USD (Acc) DEALING DATE: 3-Jan-25 NAV PER SHARE: Official NAV USD...

iShares V S&P 500 Info Tech Sc $Acc Net Asset Value(s)

iShares V S&P 500 Info Tech Sc $Acc 03 January 2025   FUND: iShares S&P 500 Information Technology Sector UCITS ETF USD (Acc) DEALING DATE: 2-Jan-25 NAV PER SHARE: Official NAV USD...

iShares V S&P 500 Info Tech Sc $Acc Net Asset Value(s)

iShares V S&P 500 Info Tech Sc $Acc 02 January 2025   FUND: iShares S&P 500 Information Technology Sector UCITS ETF USD (Acc) DEALING DATE: 31-Dec-24 NAV PER SHARE: Official NAV USD...

iShares V S&P 500 Info Tech Sc $Acc Net Asset Value(s)

iShares V S&P 500 Info Tech Sc $Acc 31 December 2024   FUND: iShares S&P 500 Information Technology Sector UCITS ETF USD (Acc) DEALING DATE: 30-Dec-24 NAV PER SHARE: Official NAV USD...

iShares V S&P 500 Info Tech Sc $Acc Net Asset Value(s)

iShares V S&P 500 Info Tech Sc $Acc 30 December 2024   FUND: iShares S&P 500 Information Technology Sector UCITS ETF USD (Acc) DEALING DATE: 27-Dec-24 NAV PER SHARE: Official NAV USD...

iShares V S&P 500 Info Tech Sc $Acc Net Asset Value(s)

iShares V S&P 500 Info Tech Sc $Acc 27 December 2024   FUND: iShares S&P 500 Information Technology Sector UCITS ETF USD (Acc) DEALING DATE: 24-Dec-24 NAV PER SHARE: Official NAV USD...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
10000000SP
40000000SP
120000000SP
260000000SP
520000000SP
1560000000SP
2600000000SP

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
VRMEVerifyMe Inc
US$ 2.57
(52.98%)
57.83M
WKEYWISeKey International Holdings AG
US$ 10.041
(52.83%)
6.72M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.65M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.17B
INTZIntrusion Inc
US$ 2.8888
(44.44%)
40.61M
IGMSIGM Biosciences Inc
US$ 2.095
(-66.21%)
5.81M
CDTGCDT Environmental Technology Investment Holdings Ltd
US$ 1.87
(-51.30%)
2.28M
MODVModivCare Inc
US$ 6.51
(-47.88%)
2.73M
AIFUAIX Inc
US$ 0.420501
(-47.76%)
7.85M
MRSNMersana Therapeutics Inc
US$ 0.691
(-46.85%)
58.44M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.17B
NVDANVIDIA Corporation
US$ 135.91
(-3.00%)
207.53M
RGTIRigetti Computing Inc
US$ 8.9299
(-11.06%)
178.82M
VMARVision Marine Technologies Inc
US$ 2.14
(40.79%)
175.57M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.65M
ORCA ORCA 4 분 전
BRO 1 MILLION SHARES DID DAMAGE??LMAO.IS THE CD THAT HATES TO SEE ANY SELLER.
AXXA
Don Faton Don Faton 4 분 전
Email got hacked unfortunately my twitter page has the new one.   Thanks PB 
SRNW
Don Faton Don Faton 6 분 전
Can we be all friends.  

I would like to know when sharp will tweet again and pull his head out of his ass. 

When we getting the supposed name and ticker change.  Nothing like the stock price bleeding down. As usual.  So frustrating 
WNFT
EmpressMonk25 EmpressMonk25 8 분 전
If you did your homework, it was clear the company had impressive products; the fault in progress was with Gensler, and the price was actually rock bottom. If you didn’t this, then maybe you weren't watching?
HMBL
jimr1717 jimr1717 9 분 전
🏆️ Filed a Form S-1 Registration Statement,
are offering shares of the Company's common stock to the public.
As soon as practicable after the effective date of this Registration Statement.

PROSPECTUS
All Things Mobile Analytic, Inc.
30,000,000 Share
ATMH
jondoeuk jondoeuk 10 분 전
KEYNOTE-D58 is a pivotal trial (N=741) of Optune concomitant with temozolomide plus keytruda in ndGBM. The estimated primary completion date is April 2029.
NVCR
Golden Cross Golden Cross 10 분 전
$ILLR Triller is the Majority owner of Bare Knuckle Fighting Championship (#BKFC).
This is just one major part of Triller!

1. Triller is Majority Owner of BKFC.
2. World Famous Conor McGregor is Part-Owner
3. $25 Million Tournament Coming up!
4. BKFC is the
ILLR
Golden Cross Golden Cross 12 분 전
$ILLR Triller is the Majority owner of Bare Knuckle Fighting Championship (#BKFC).
This is just one major part of Triller!

1. Triller is Majority Owner of BKFC.
2. World Famous Conor McGregor is Part-Owner
3. $25 Million Tournament Coming up!
4. BKFC is the
ILLR
Kool Aid Man Kool Aid Man 12 분 전
I can't wait for the PR explaining the need for 700 million more shares. Never ending source of entertainment
SPZI
dstock07734 dstock07734 12 분 전
Gary,

I strongly suggest you go through the details of all the outcome measures adopted in the combo trial. They are so disruptive. I also think we should abandon the old concept about the definition of phase on clinical trials. The phase definition for DCVax-L doesn't matter. What it
NWBO
manibiotech manibiotech 13 분 전
Yep you did get it straight .
There is a reason companies apply to FDA and EMA . And there is reason for current SP.
But problem is that when given  straight to you , you can't comprehend straightforward reasons 
NWBO
Lime Time Lime Time 14 분 전
Very good opportunity
GVSI
gshores gshores 18 분 전
Nothing personal, but you reek of desperation for some reason. Longs will do great here.
SPZI
jondoeuk jondoeuk 19 분 전
Data from the PhII 2-THE-TOP trial https://www.onclive.com/view/temozolomide-pembrolizumab-plus-ttfields-leads-to-tumor-control-in-newly-diagnosed-glioblastoma
NVCR
kBletsgo30 kBletsgo30 20 분 전
Yeah right 
RSPI
ddls ddls 20 분 전
Maybe you should double down, buy 10M shares...😎

Just watch out for these types of days..."1/3/25, Buy: 1,300,000, Neutral: 366,005, Sell: 66,963,117.😎

You'll be seeing more of them.
BIEL
XMaster2023 XMaster2023 24 분 전
I would take your bet but you have the ethics of someone who would work for an idiot who would try to kill a cure for cancer. Thus, I would never trust you!
NWBO
manibiotech manibiotech 26 분 전
And someone to pay NWBO ( not advent ) for those treatments 
NWBO
StockItOut StockItOut 29 분 전
Are they really? That's evidence of a scam.
XERI
skitahoe skitahoe 29 분 전
Dstocks, it's clear that many are interested in the kind of work we're doing. My question is, are any beyond the Phase 1/2 trials.

I believe we're clearly the leaders here and with approvals while it may make it easier for others, they'll still be many years before the can possibly g
NWBO
vinmantoo vinmantoo 31 분 전
Have you seen the stock price?

Enough said.

The stock price alone certainly isn't enough said.
Eagle1 Eagle1 34 분 전
SDCRBS, Please let me know if I can help you in any way. Just DM me. I'm sorry and sad to see all this CA and LA destruction.

I'm in the Houston area and couldn't imagine this type of destruction.

So Sorry.
GDVM
Plasmode Plasmode 38 분 전
I’ve learned so much from valuable contributors like Mr C and Dino and great respects for your researches and insights, then this kind of bickering just knock you off the pedestal into muck. Just respond with ‘next’ if you refuse to lower yourself into the mud. I have more respect for people like
TGLO
elks elks 39 분 전
Tic toc
GVSI
jondoeuk jondoeuk 41 분 전
Translational data from the PhI B-cell lymphomas trial demonstrated primary, secondary and tertiary tissue trafficking and clearance of CD19+ cells. That should help enable an immune reset in autoimmune diseases.

The next-gen CAR-T's will incorporate a suite of novel synthetic edits t
FATE